Corporate insider profile
Brian M Culley Insider Trades
Brian M Culley has reported 1 open-market purchase on SEC Form 4 and is a net buyer of $37,098 across 1 company. The most recent open-market transaction was reported on Nov 16, 2026. Source: SEC Form 4 filings.
Latest reported as President and CEO of Lineage Cell Therapeutics, Inc. (LCTX).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $37,098
- Latest transaction
- Nov 16, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Brian M Culley insider trading FAQ
- Is Brian M Culley buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Brian M Culley is a net buyer of $37,098, with 1 open-market purchase reported. The latest transaction was reported on Nov 16, 2026.
- Which companies does Brian M Culley report insider trades for?
- Brian M Culley has reported open-market trades in Lineage Cell Therapeutics, Inc. (LCTX). The latest SEC-reported relationship is President and CEO of Lineage Cell Therapeutics, Inc. (LCTX).
- Where does Brian M Culley's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1310683, and refreshes this page daily.
